Reid Hoffman Exits Microsoft Board for AI Drug Startup
Reid Hoffman is walking away from one of tech’s most prestigious board seats. The LinkedIn co-founder and legendary venture capitalist…
Reid Hoffman is walking away from one of tech’s most prestigious board seats. The LinkedIn co-founder and legendary venture capitalist…
Chai Discovery cofounders Josh Meier (left) and Jack Dent Cody Pickens for Forbes L ast June, when AI drug discovery…
ProteinQure’s co-founder argues “messy biology experiments” are still the bottleneck. Quantum chemistry has been touted as having the potential…
New York-based Solstice raised $21M in Series A funding led by Transformation Capital, bringing total funding to nearly $25M The…
Protuoso Biosciences has secured $9.5m in seed financing to develop its platform which combines multiple therapeutic modalities to target diseases…
A startup founded by University of Toronto alumni has won Silicon Valley buy-in for its novel approach to AI-assisted drug…
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma…
AI drug discovery race, PIF’s LIV Golf pullback, and Thoma Bravo’s Google deal Axios Source link
B Capital announced it has been selected as a registered venture capital firm under the Agency for Medical Research and…
• 6 hours ago • 3 Mins Read The platform integrates advanced AI to predict molecular behavior, identify potential drug…
Migraine treatment took a leap forward with CGRP inhibitors, a drug class that has progressed from novel medicines to first-line…
Alzheimer’s disease can be treated with antibodies that clear away plaques of amyloid protein, but these medicines require frequent dosing…
AI startup Iambic on Monday announced a multi-year technology and discovery collaboration agreement with Takeda Pharmaceutical Company Limited (NYSE:TAK). The…
Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques,…
AI healthcare concept stocks in the Hong Kong stock market collectively surged, $FANGZHOU JIANKE (06086.HK)$ with some rising over 36%,…
‘Scientist-as-a-Service’: Seattle startup Pauling.AI aims to shrink drug discovery timelines by months GeekWire Source link
AI-for-Science Startup ChemLex Raises $45M, Launching Self-Driving Lab for Drug Discovery in Singapore AI Insider Source link
ChemLex, a next-generation artificial intelligence (AI)-for-science company, has announced the establishment of its global headquarters and self-driving laboratory in Singapore,…